Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
2.
Anaesthesia ; 75(5): 634-641, 2020 05.
Article in English | MEDLINE | ID: mdl-32030734

ABSTRACT

Intra-operative hypotension is a known predictor of adverse events and poor outcomes following major surgery. Hypotension often occurs on induction of anaesthesia, typically attributed to hypovolaemia and the haemodynamic effects of anaesthetic agents. We assessed the efficacy of fluid optimisation for reducing the incidence of hypotension on induction of anaesthesia. This prospective trial enrolled 283 patients undergoing radical cystectomy and randomly allocated them to goal-directed fluid therapy (n = 142) or standard fluid therapy (n = 141). Goal-directed fluid therapy patients received fluid optimisation based on stroke volume response to passive leg raise before induction; those with positive passive leg raise received intravenous crystalloid fluid boluses until stroke volume was optimised. Baseline mean arterial pressure was measured on the morning of surgery and on arriving in the operating theatre. This post-hoc analysis defined haemodynamic instability as either a > 30% relative drop in mean arterial pressure compared with baseline or absolute mean arterial pressure < 55 mmHg, within 15 min of induction. Forty-two (30%) goal-directed fluid therapy patients underwent fluid optimisation after finding an intravascular fluid deficit via passive leg raise testing; 106 (75%) goal-directed fluid therapy and 112 (79%) standard fluid therapy patients met criteria for haemodynamic instability. There was no significant difference in the incidence of haemodynamic instability between the goal-directed fluid therapy and standard fluid therapy groups using absolute mean arterial pressure drop below 55 mmHg (p = 0.58) or using pre-surgical testing or pre-surgical mean arterial pressure values as baseline (p = 0.21, p = 0.89, respectively); however, the difference in the incidence of haemodynamic instability was significant using the operating theatre baseline mean arterial pressure (p = 0.004). We conclude that fluid optimisation before induction of general anaesthesia did not significantly impact haemodynamic instability.


Subject(s)
Anesthesia/methods , Fluid Therapy/methods , Hypotension/prevention & control , Intraoperative Complications/prevention & control , Adult , Aged , Aged, 80 and over , Arterial Pressure , Crystalloid Solutions/administration & dosage , Cystectomy , Electrocardiography , Female , Goals , Hemodynamics , Humans , Leg/blood supply , Male , Middle Aged , Prospective Studies , Single-Blind Method , Stroke Volume
3.
Ann Surg Oncol ; 20(8): 2477-84, 2013 Aug.
Article in English | MEDLINE | ID: mdl-23608971

ABSTRACT

BACKGROUND: Perioperative outcomes, such as blood loss, transfusions, and morbidity, have been linked to cancer-specific survival, but this is largely unsupported by prospective data. METHODS: Patients from a previous, randomized trial that evaluated acute normovolemic hemodilution during major hepatectomy (≥3 segments) were reevaluated and those with metastatic colorectal cancer (n = 90) were selected for analysis. Survival data were obtained from the medical record. Disease extent was measured using a clinical-risk score (CRS). Log-rank test and Cox proportional hazard model were used to evaluate recurrence-free survival (RFS) and overall survival (OS). RESULTS: Median follow-up was 71 months. The CRS was ≥3 in 45 % of patients; 59 % had extrahepatic procedures. Morbidity and mortality were 33 and 2 %, respectively. Postoperative chemotherapy was given to 87 % of patients (78/90) starting at a median of 6 weeks. RFS and OS were 29 and 60 months, respectively. Postoperative morbidity significantly reduced RFS (23 vs. 69 months; P < 0.001) and OS (28 vs. 74 months; P < 0.001) on uni- and multi-variate analysis; positive resection margins and high CRS also were significant factors. Delayed initiation of postoperative chemotherapy (≥8 weeks) was common in patients with complications (37 vs. 12 %; P = 0.01). CONCLUSIONS: In this selected cohort of patients from a previous RCT, perioperative morbidity was strongly (and independently) associated with cancer-specific outcome. It also was associated with delayed initiation of postoperative chemotherapy, the impact of which on survival is unclear.


Subject(s)
Blood Loss, Surgical , Colorectal Neoplasms/pathology , Hemodilution , Hepatectomy/adverse effects , Liver Neoplasms/surgery , Transfusion Reaction , Abdominal Abscess/etiology , Chemotherapy, Adjuvant , Disease-Free Survival , Equipment Failure , Female , Hospital Mortality , Humans , Ileus/etiology , Infusion Pumps, Implantable/adverse effects , Length of Stay , Liver Neoplasms/drug therapy , Liver Neoplasms/secondary , Male , Middle Aged , Multivariate Analysis , Myocardial Ischemia/etiology , Neoplasm, Residual , Recurrence , Risk Assessment , Surgical Wound Infection/etiology , Survival Rate , Tachycardia/etiology , Time Factors , Venous Thrombosis/etiology
SELECTION OF CITATIONS
SEARCH DETAIL
...